Recently Viewed


    Sheff Joined Oct 31, 2011


    1. Thumb-1408315779
      Daniel Ward
      Investment Banking Analyst with experience as prop trader on the Street as well as working in asset management. CFA candidate and Seeking Alpha writer. Specializing in value biotech and write Biotech Weekly. Personal opinions, not investment advice.
    2. Thumb-1398524326
      joe donohue Official Account
    3. Thumb-1317657617
      Bill Gunderson Official Account
      President of Gunderson Capital Mgt. Host of nationally syndicated Best Stocks Now Radio Hour. Inventor of Best Stocks Now app. Frequent contributor to Fox, CNBC, Marketwatch & TheStreet.
    4. Thumb-1359502628
      We parse and analyze SEC filings and give users an easy way explore important public information about companies, securities, and asset managers
    5. Thumb-1291730913
      StreetInsider Official Account
      If you like our tweets, you'll love SI Premium. 2-week free trial at the site.
    6. Thumb-1347585334
      Carefully selected and promising stocks (mostly biotechs). My successful trading strategy combines undiscovered/undervalued bio-plays with the best chart and momentum based entry.
    7. Thumb-1441581297
      Skilled & experienced traders. Swing/day trades, options, long/short. We have nightly trade plan to make $ everyday. Join us, trade as you growth.
    8. Thumb-1398461724
      David Shvartsman
      Founder/Editor of the blog, Finance Trends. A trader's view of the stock market and emerging financial trends.
    9. Thumb-1354209363
      Red Acre Investments
      Binary Event Specialists & Fund Managers, Become a Better, Smarter, More Profitable Biotech Investor. Subscribe to the FREE Red Acre Review at
    10. Thumb-1360937874
      Jesse Stine
      Author- Insider Buy Super Stocks (2013). $46k to $6.8 million in 28 months (14,972%). My Bread and Butter: The intersection of deep value and extreme momentum. Twitter- @InsiderBuySS
    11. Thumb-1435023529
      JOIN FREE TODAY! for forecasts & research reports +Sunday Weekend edition-8-13 ideas weekly. :Our SRP Swing Trading Service has beat SP 500 6 to 1 since inception.
    12. Thumb-1441054403
    13. Thumb-1396447514
      Primary interest is Bio with intriguing pipelines that have large growth potential. I attempt to hold >50% of positions LT unless negative data, mgmt. concerns, or known negative events. Diversify and only trade in spec what you can lose.
    14. Thumb-1441472584
      Been playing Biotechs since life began , options player , everything player. I trade , use fundamentals, technicals , willing to take risk. We are in a bull market if you don't end up retiring by the end of it you messed up.
    15. Thumb-1414801948
      Arun Chopra CFA, CMT Official Account
      All charts/comments strictly for information and educational purposes only. Suitability, specific circumstances not taken into account. Comments/posts are idea generation only, do your own due diligence.
    16. Thumb-1410895692
      Adam Singer Official Account
      Analytics geek and investor / trader. All information for fun / I am not a financial advisor. I take risks so you probably shouldn't take my advice. Do your own DD.
    17. Thumb-1408766055
      Vision without a plan is just a dream. Plan our trades and trade our plans. Business person of the year. Invest in game changers. Using both FA and TA for trading. Equities, ETFs, rarely options.
    18. Thumb-1404437647
      Shane Obata-Marusic
      Global macro, psychology, history, politics, fundamentals, technicals, FX, rates, equities, options, R. MFin candidate. Passed L 3 of the CFA program - Jun'15. @sobata416
    19. Thumb-1341694465
      So Generous
      Financial Engineer. Big on Biotech. Using technical analysis, I am able to consistently produce profitable trades & abnormal returns. Made 1,000%+ on FB, NFLX, and REGN options. My goal is to become the greatest investor and trader that ever lived.
    20. Thumb-1395880877
      S D
      In a December 1997 issue of Barron's, a Merrill Lynch poll found that the top strategy among 122 institutions surveyed was to buy stocks of companies that exceed earnings expectations and sell the companies that fall short.